Subscriber login
DrugPatentWatch -- sales, statistics, drug application information
ADVERTISE HERE 

DrugPatentWatch

Pharmaceutical Innovation Dashboard

Your Source for Pharmaceutical Industry Intelligence

Ultimate Plan

compare plans
Drug therapeutic classDrug patent expirationsPatent expiration datesAnnual drug sales
$475 / One Month $1,895 / One Year
One MonthOne Year
Need an invoice? Group rate? Contact admin@DrugPatentWatch.com

Drug Patent Expirations in February 2010

*Drugs may be covered by multiple patents
Tradename Applicant Generic Name Patent Number Patent Expiration
ZAGAMMylansparfloxacin4,795,751Feb 4, 2010
TEVETENAbbotteprosartan mesylate5,185,351Feb 9, 2010
MYOVIEWGe Healthcaretechnetium tc-99m tetrofosmin kit5,045,302Feb 9, 2010
TEVETEN HCTAbbotteprosartan mesylate; hydrochlorothiazide5,185,351Feb 9, 2010
HYZAARMerckhydrochlorothiazide; losartan potassium5,138,069*PEDFeb 11, 2010
COZAARMercklosartan potassium5,138,069*PEDFeb 11, 2010
EXUBERAPfizerinsulin recombinant humanRE37872Feb 12, 2010
EXUBERAPfizerinsulin recombinant humanRE38385Feb 12, 2010
MEPRONGlaxosmithklineatovaquone4,981,874*PEDFeb 15, 2010
NITRO-DURKey Pharmsnitroglycerin5,186,938Feb 16, 2010
SANDIMMUNENovartiscyclosporine7,511,014Feb 16, 2010
ALDARAGracewayimiquimod4,689,338*PEDFeb 25, 2010


Subscribe to Free Drug Patent Expiration Updates

Enter your email address:  
Also available in a Drug Patent Expiration NewsletterRSS feed and on Twitter

 

 

Drug patent expirations by month

Drug patent expirations by year

Number of drug patents per pharmaceutical drug 		Number of drugs per drug company

Most patents listed last year

Number of drug patents by drug company 		Number of pharmaceutical patent expirations faced by drug companies

Number of approved drugs produced per company

Top selling drugs

Database Preview

[ Home | Site Tour | Free Patent Expiration Newsletter | Affiliate Program | Contact ]
Drug Patent ExpirationsFollow DrugPatentWatch on Twitter
[del.icio.us] [Digg] [LinkedIn] [StumbleUpon] [Technorati] [Twitter] [Email]
Bookmark & Share

Pharmaceutical industry competitive intellgence